Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

beta(2)-Adrenoceptors and ventricular fibrillation.

R A Altschuld1, G E Billman

  • 1Department of Medical Biochemistry, The Ohio State University College of Medicine and Public Health, 333 Hamilton Hall, 1645 Neil Avenue, Columbus, OH 43210-1218, USA.Altschund.2@osu.edu

Pharmacology & Therapeutics
|October 18, 2000
PubMed
Summary

Beta-blockers reduce sudden cardiac death by targeting beta-adrenoceptors. Selective beta(2)-adrenoceptor blockade prevents fatal arrhythmias, offering a new therapeutic strategy for contractile dysfunction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translational neurocardiology: preclinical models and cardioneural integrative aspects.

The Journal of physiology·2016
Same author

n-3 (omega-3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodeling.

British journal of pharmacology·2006
Same author

Membrane effects of the n-3 fish oil fatty acids, which prevent fatal ventricular arrhythmias.

The Journal of membrane biology·2006
Same author

Experimental studies on antiarrhythmic and antiseizure effects of polyunsaturated fatty acids in excitable tissues.

The Journal of nutritional biochemistry·2004
Same author

KB-R7943. Kanebo.

Current opinion in investigational drugs (London, England : 2000)·2002
Same author

Enhanced in vivo and in vitro contractile responses to beta(2)-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias.

Journal of applied physiology (Bethesda, Md. : 1985)·2001

Area of Science:

  • Cardiology
  • Molecular Pharmacology

Background:

  • Contractile dysfunction involves altered beta-adrenoceptor (β-AR) signaling, with decreased β(1)-AR and unchanged β(2)-AR levels.
  • Increased responsiveness to β(2)-AR stimulation is observed in contractile dysfunction.

Purpose of the Study:

  • To investigate the role of β(2)-AR in sudden cardiac death and ventricular fibrillation.
  • To explore the mechanisms underlying β(2)-AR-mediated arrhythmogenesis.

Main Methods:

  • Utilized a canine model of sudden cardiac death.
  • Examined the effects of selective β(2)-AR blockade on ventricular fibrillation.
  • Assessed cardiac ion currents and intracellular calcium handling.

Main Results:

  • Selective β(2)-AR blockade prevented ventricular fibrillation in a cardiac dysfunction model.

Related Experiment Videos

  • β(2)-AR stimulation increased L-type Ca(2+) currents but did not phosphorylate phospholamban.
  • Enhanced Ca(2+) influx via β(2)-AR relies on Na(+)/Ca(2+) exchange, promoting arrhythmogenic currents.

    • Conclusions:

    • Targeting β(2)-AR offers a novel approach to prevent sudden cardiac death in patients with contractile dysfunction.
    • The arrhythmogenic potential of β(2)-AR stimulation is linked to Na(+)/Ca(2+) exchange activity.